Catalyst Wire Dossier Catalyst Wire Dossier

Epivir (lamivudine)

lamivudine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Epivir (lamivudine), covering 2007-11-01 to 2016-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients [Phase 4]

See pricing